Results 131 to 140 of about 1,374,790 (199)

Durability of Blood Pressure Reduction After Renal Denervation in Resistant Hypertension: Mid-Term Real-World Outcomes From Kuwait. [PDF]

J Clin Hypertens (Greenwich)
Alansari YE, Abed BS, Abed BS, Alqouba M, Alsayegh A, Alawadi A, Roomi FA, Mehana M, Almandeel B, Alothman O, Elsanadidy N, Tifooni A, Mula KFAA.   +12 more
europepmc   +1 more source

TREAT: A Multicentre Cross-sectional TReatment Evaluation of Apparent Resistant hyperTension in Belgium. [PDF]

J Clin Hypertens (Greenwich)
Sofie B, Justine H, Mathilde C, Bregt VN, Dirk B, Daniel M.   +5 more
europepmc   +1 more source

Endothelial triple-pathway vasorelaxation as an adjunctive strategy in resistant hypertension. [PDF]

J Hypertens
Madeddu P, Cattaneo M, Giuffre M, Laffin LJ.   +3 more
europepmc   +1 more source

The role of the sympathetic nervous system in the pathomechanism and the therapy of hypertension [PDF]

, 2014
Légrády Péter
core  

Non-coding RNA biomarkers in resistant hypertension: a scoping review. [PDF]

Front Mol Biosci
Błaszczyk R, Biskupski M, Wiśniowski Ł, Kondracki B, Siwiec J, Mlak R, Głowniak A.   +6 more
europepmc   +1 more source

Comparative Efficacy of Aldosterone-Related Sodium-Retention Pathway Therapies for Resistant Hypertension: A Drug-Level Network Meta-Analysis of Randomized Controlled Trials. [PDF]

J Clin Hypertens (Greenwich)
Tsou YL, Wang YH, Lin YS, Chen CL.
europepmc   +1 more source

Amiloride: revisiting an old drug for resistant hypertension. [PDF]

Clin Hypertens
Lee CJ, Park S.
europepmc   +1 more source

Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. [PDF]

N Engl J Med
Flack JM, Azizi M, Brown JM, Dwyer JP, Fronczek J, Jones ESW, Olsson DS, Perl S, Shibata H, Wang JG, Wilderäng U, Wittes J, Williams B, BaxHTN Investigators.   +13 more
europepmc   +1 more source

Aprocitentan in resistant hypertension with chronic kidney disease: balancing albuminuria reduction against early volume risk. [PDF]

J Hum Hypertens
Corrêa LMA, Silva YRD, Zanella J, de Santana GC.   +3 more
europepmc   +1 more source

Baxdrostat as a catalyst for precision hypertension: integrating pharmacogenomics, omics biomarkers, and digital phenotyping in resistant hypertension management. [PDF]

Clin Hypertens
Amjad A, Batool ST, Ali U.
europepmc   +1 more source